Wellington Management Group LLP Buys Shares of 22,860 Grail, Inc. (NASDAQ:GRAL)

Wellington Management Group LLP bought a new stake in Grail, Inc. (NASDAQ:GRAL - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 22,860 shares of the company's stock, valued at approximately $408,000. Wellington Management Group LLP owned approximately 0.07% of Grail at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the company. FNY Investment Advisers LLC purchased a new position in Grail in the 4th quarter valued at $26,000. Lindbrook Capital LLC acquired a new position in Grail during the fourth quarter worth about $28,000. Wellington Shields Capital Management LLC purchased a new stake in Grail during the 4th quarter valued at about $33,000. New York State Common Retirement Fund purchased a new stake in Grail during the 4th quarter valued at about $59,000. Finally, Wilmington Savings Fund Society FSB acquired a new stake in Grail in the 4th quarter valued at about $64,000.

Insider Buying and Selling at Grail

In other Grail news, CEO Robert P. Ragusa sold 7,625 shares of Grail stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $31.21, for a total transaction of $237,976.25. Following the completion of the sale, the chief executive officer now directly owns 828,662 shares in the company, valued at $25,862,541.02. This trade represents a 0.91 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Aaron Freidin sold 1,816 shares of the company's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.20, for a total transaction of $56,659.20. Following the completion of the transaction, the chief financial officer now owns 335,170 shares in the company, valued at approximately $10,457,304. This represents a 0.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 11,550 shares of company stock worth $360,436 over the last quarter.

Analyst Upgrades and Downgrades

Separately, Morgan Stanley increased their price target on Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a report on Tuesday, March 18th.

Remove Ads

Grail Price Performance

Shares of GRAL opened at $24.85 on Tuesday. Grail, Inc. has a 12-month low of $12.33 and a 12-month high of $63.99. The firm has a 50-day moving average price of $33.33 and a 200 day moving average price of $23.34.

Grail (NASDAQ:GRAL - Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, beating the consensus estimate of ($4.41) by $2.55. The firm had revenue of $38.25 million during the quarter, compared to analysts' expectations of $35.33 million. On average, sell-side analysts anticipate that Grail, Inc. will post -15.15 earnings per share for the current year.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

Want to see what other hedge funds are holding GRAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Grail, Inc. (NASDAQ:GRAL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.